Related Experiment Video
Updated: Jan 18, 2026

08:49
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
9.9K
Optimized FDA Blood Pump: A Case Study in System-Level Customized Ventricular Assist Device Designs
Canberk Yıldırım1, Kağan Uçak2, Ali Madayen3
1Department of Biomedical Engineering, Koc University, 34060, Istanbul, Turkey.
Annals of Biomedical Engineering
|September 9, 2025
Summary
This study introduces an efficient framework for designing ventricular assist devices (VADs), significantly reducing hemolysis and blood-wetted area. The new approach optimizes VADs for better patient hemodynamics and shorter development cycles.
Area of Science:
- Biomedical Engineering
- Medical Device Design
- Computational Fluid Dynamics
Background:
- Ventricular assist device (VAD) development traditionally relies on computational fluid dynamics (CFD), often involving lengthy trial-and-error processes.
- Existing CFD optimization methods for VADs are time-consuming and resource-intensive, necessitating more efficient approaches.
Purpose of the Study:
- To develop and present a novel, efficient framework for VAD design and optimization.
- To overcome the limitations of traditional CFD-based trial-and-error optimization methods in VAD development.
Main Methods:
- Coupled a lumped parameter cardiovascular model with turbomachinery and blade path design packages for system-level optimization.
- Incorporated pump hydrodynamic losses and validated the framework against experimental data and CFD simulations.
- Enabled specification of physiology- and device-related objectives for broad parameter space optimization.
Main Results:
- Applied optimization to the FDA benchmark blood pump, achieving ~32% reduction in blade tip velocity and ~88% reduction in hemolysis.
- Generated an alternative design with 40% less blood-wetted area while maintaining baseline pressure and flow.
- Demonstrated significant improvements in pump performance and design efficiency.
Conclusions:
- The proposed framework enhances VAD development efficiency by shortening design cycles.
- Enables the creation of hydrodynamically optimized pumps suitable for diverse patient hemodynamics.
- Optimized VAD designs are provided as open-source resources for future research.
Keywords:
Benchmark devicesCardiovascular engineeringComputational fluid dynamicsFDA blood pumpLumped parameter modelingOptimizationVentricle assist devicesMore Related Videos
Related Concept Videos
Heart Failure VI: Adjunct Therapies
263
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
263
Cardiomyopathy V: Interprofessional Care
343
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
343

